Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
AORT

AORT - Artivion, Inc. Stock Price, Fair Value and News

$41.29-0.19 (-0.46%)
Market Closed

28/100

AORT

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

28/100

AORT

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$34.42

Target 3M

$39.41

Target 6M

$36.57

AORT Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

AORT Price Action

Last 7 days

-6.8%

Last 30 days

-10.9%

Last 90 days

-9.5%

Trailing 12 Months

33.0%

AORT RSI Chart

AORT Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

AORT Valuation

Market Cap

2.0B

Price/Earnings (Trailing)

-213.99

Price/Sales (Trailing)

4.63

EV/EBITDA

143.3

Price/Free Cashflow

111.78

AORT Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$34.42

Target 3M

$39.41

Target 6M

$36.57

AORT Fundamentals

AORT Revenue

Revenue (TTM)

422.6M

Rev. Growth (Yr)

18.39%

Rev. Growth (Qtr)

0.37%

AORT Earnings

Earnings (TTM)

-9.1M

Earnings Growth (Yr)

384.18%

Earnings Growth (Qtr)

383.42%

AORT Profitability

EBT Margin

-1.98%

Return on Equity

-2.08%

Return on Assets

-1.07%

Free Cashflow Yield

0.89%

AORT Investor Care

Shares Dilution (1Y)

13.01%

Diluted EPS (TTM)

-0.24

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025390.1M405.0M422.6M0
2024368.2M377.0M384.9M388.5M
2023319.8M328.7M339.7M354.0M
2022305.0M309.2M313.8M313.8M
2021257.9M280.3M287.3M298.8M
2020275.1M257.8M255.0M253.2M
2019268.4M271.0M274.3M276.2M
2018206.6M227.3M247.9M262.8M
2017182.4M183.2M181.9M189.7M
2016155.1M166.6M175.2M180.4M
2015142.7M143.6M143.2M145.9M
2014141.0M142.1M142.9M144.6M
2013135.0M135.3M138.1M140.8M
2012121.7M125.5M129.3M131.7M
2011117.1M117.2M118.5M119.6M
2010000116.6M
Get all data in R, Python etc through our Historical Stock Data APIs

About Artivion, Inc.

AORT
Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita Open Plus and E-vita Open Neo. It also provides E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent and graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia.
 CEO
 WEBSITEhttps://artivion.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES1300

Artivion, Inc. Frequently Asked Questions

AORT is the stock ticker symbol of Artivion, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Artivion, Inc. is 1.96 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check AORT's fair value in chart for subscribers.

The fair value guage provides a quick view whether AORT is over valued or under valued. Whether Artivion, Inc. is cheap or expensive depends on the assumptions which impact Artivion, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AORT.

As of Wed Jan 28 2026, AORT's PE ratio (Price to Earnings) is -213.99 and Price to Sales (PS) ratio is 4.63. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AORT PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Artivion, Inc. has provided 0.154 (multiply by 100 for percentage) rate of return.